CV Sciences (CVSI) Net Margin (QoQ) (2013 - 2026)
CV Sciences (CVSI) Net Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -584.00 |
| Mar 31, 2026 | -2,499.00 |
| Dec 31, 2025 | 1,660.00 |
| Sep 30, 2025 | -452.00 |
| Jun 30, 2025 | -419.00 |
| Mar 31, 2025 | 895.00 |
| Dec 31, 2024 | -17.00 |
| Sep 30, 2024 | 297.00 |
| Jun 30, 2024 | 92.00 |
| Mar 31, 2024 | 717.00 |
| Dec 31, 2023 | -1,193.00 |
| Sep 30, 2023 | 2,154.00 |
| Jun 30, 2023 | -17,004.00 |
| Mar 31, 2023 | 19,734.00 |
| Dec 31, 2022 | -3,230.00 |
| Sep 30, 2022 | 5,886.00 |
| Jun 30, 2022 | -3,879.00 |
| Mar 31, 2022 | 13,068.00 |
| Dec 31, 2021 | -17,746.00 |
| Sep 30, 2021 | 6,805.00 |